1. Home
  2. > Healthcare
  3. > Medical Device
  4. > Respiratory Device Market Trends
Respiratory Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, and End User

Respiratory Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, and End User

  • May 2022
  • 347 pages
  • ID: 6289934
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The respiratory care devices market is expected to grow from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028; it is expected to grow at a CAGR of 8.9% from 2021 to 2028.

The report highlights trends prevailing in the market and factors driving the respiratory care devices market.The respiratory care devices market growth is attributed to the increasing prevalence of infectious respiratory diseases, rapidly increasing cases of asthma and COPD, rising number of product launches and approvals, and growing R&D investment for respiratory care devices.

However, cutthroat competition among market players and unfavorable reimbursement scenarios are hampering market growth.

Respiratory care devices include devices intended to assist patients during respiratory disease management.The most commonly used respiratory care devices are oxygen concentrators, ventilators, nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, etc.

These devices mainly perform therapeutic, diagnostic, and monitoring functions.

Rapidly Increasing Cases of Asthma and COPD: Respiratory Care Devices Market Growth
Chronic respiratory diseases (CRDs) affect the airways and other structures of the lungs.The most common CRDs are chronic obstructive pulmonary diseases (COPD), asthma, occupational lung diseases, and pulmonary hypertension.

Asthma and COPD symptoms and causes are equivalent to the signs of the COVID-19, which indicates the respiratory devices used in their treatment are quite common.According to the paper published by the Journal of Allergy and Clinical Immunology, in 2020, patients with COPD and asthma increased adherence to inhalers medications during the Covid-19 pandemic.

Moreover, in 2020, the number of inhalers prescribed by general practitioners in England increased by 63% between February 2020 and March 2020, as stated by the National Health Service (NHS).Further, some parts of the world, such as the UK and the US, experienced shortages of inhalers because of their use during the COVID-19.

Thus, COVID-19 has propelled the growth and opportunities for the manufacturers of COPD and Asthma devices.
Among all CRDs, Asthma is one of the most common and popular non-communicable diseases which affect all ages.The prevalence of asthma is increasing at an alarming rate due to a rise in allergic reactions toward pollen, dust, and other allergens, increasing environmental pollution.

The main symptoms of asthma include cough, wheeze, shortness of breath, and chest tightness. Below are a few facts and statistics about asthma that drive the market for respiratory care devices:
• According to WHO, in 2019, asthma affected approximately 262 million people and caused 4.5 million deaths.
• The US and the UK have exceptionally high asthma rates among all the regions. According to an article published in British Medical Journal (BMJ), in the UK, asthma-associated deaths increased by 33% between 2008 and 2018.
• The US statistics reveal that 25 million people in the US have asthma. The stats equal 1 in every 13 people, as stated by the Asthma and Allergy Foundation of America, 2021.
• However, asthma is more common in male children than female children. Around 3.3% of male children have asthma, compared to 1.6% of female children, according to AAFA 2021 report.
• According to the CDC, secondhand smoke causes children to have more asthma attacks.
Further, COPD encompasses a group of lung diseases caused by persistent airflow limitation, prolongation of exhalation, and loss of lung elasticity.It is a progressive and debilitating disease associated with an increased inflammatory response in the airways.

According to an article published in The Lancet in May 2022, the global prevalence of COPD was 10.3% in 2019, accounting for 391.9 million cases among people aged 30–79 years. According to WHO, COPD is the 3rd leading cause of death worldwide, causing 3.23 million deaths in 2019. Thus, the rising prevalence of COPD increased the demand for respiratory care devices. As per the American Society of Health-System Pharmacists (ASHP), currently, there are four types of devices to deliver various COPD medications: pressurized metered-dose inhalers (pMDI), dry powder inhalers (DPI), soft mist inhalers (SMI), and nebulizers. Below are the examples of medications requiring respiratory care devices for COPD inhaled therapies.

Various drug-delivery protocols, such as parenteral and oral drug delivery, are developed to treat asthma and COPD.However, the most effective treatment option is the pulmonary drug delivery system, compared to the other conventional methods.

Thus, the factors mentioned above, such as the rising prevalence and cases of Asthma and COPD, and the rise in demand for respiratory care devices, are expected to boost the market growth.

Respiratory Care Devices Market Insights
The global respiratory care devices market is segmented based on product, indications, end user, and geography.Based on product, the market is segmented into therapeutic devices, monitoring devices, diagnostics devices, and consumables & accessories.

The therapeutic devices segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period.Based on indication, the global respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others.

The COPD segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period.Based on end user, the global respiratory care devices market is segmented into hospitals, home care, and ambulatory care.

The hospitals segment held the largest market share in 2021, and it is anticipated to register the highest CAGR during the forecast period. Based on geography, the respiratory care devices market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2021; however, Asia Pacific is anticipated to register the highest CAGR during the forecast period.

World Health Organization (WHO), Pan American Health Organization (PAHO), Center for Disease Control and Prevention, International Journal of Environment Research and Public Health, National Center for Health Statistics, and Japanese Red Cross Society (JRC) are among the primary and secondary sources referred to while preparing the report on the respiratory care devices market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asia Pacific Respiratory Care Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Indication [Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Diseases, and Others], and End User

  • $ 3000
  • August 2022
  • 268 pages

The Asia Pacific respiratory care devices market is expected to grow from US$ 4,543.26 million in 2022 to US$ 8,089.96 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2022 to 2028. Medical ...

  • APAC
  • Respiratory Device
  • Industry analysis
  • Smoking Prevalence
  • Asthma Prevalence

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on